OFIX
Orthofix Medical Inc. Common Stock (DE)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
OFIX Stock Analysis: Buy, Sell, or Hold?
$6.87
-0.31 (-4.37%)
▼
5d:
-23.02%
30d:
-25.77%
90d:
-33.6%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
45/100
Position
OVERSOLD
30-Day Fair Range
$8.78 – $9.87
Position: OVERSOLD
Forward P/E & Valuation
19.4x
FAIR
vs 20.8x historical avg
Wall Street Target
$10.75
+49.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.52 / $10.29
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: OFIX is down 23.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When OFIX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.60
Based on -2.9% avg growth
INTRINSIC VALUE TODAY
$4.10
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OFIX is currently trading at $6.87, which is considered oversold relative to its 30-day fair value range of $8.78 to $9.87. The stock's valuation (Forward PE: 19.4) is in line with its historical norms (20.8). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OFIX is in a downtrend. Immediate support is located at $6.52, while resistance sits at $10.29. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.75 (+49.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OFIX is in a downtrend. Immediate support is located at $6.52, while resistance sits at $10.29. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $10.75 (+49.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$8.78 -
$9.87
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
Trading Range & Key Levels
30-Day Trading Range
$8.78 -
$9.87
Current vs Trading Range
OVERSOLD
Support Level
$6.52
Resistance Level
$10.29
Current Trend
Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 49.7% below Wall St target ($10.75)
- WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
19.41
Wall Street Target
$10.75
(+49.7%)
Revenue Growth (YoY)
3.8%
Profit Margin
-7.4%
Valuation Discount vs History
-2.3% cheaper
PE vs Historical
19.4 vs 20.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.3%
(market-implied from PE analysis)
1-Year Target
$7.01
(-2%)
2-Year Target
$6.85
(-5%)
3-Year Target
$6.70
(-7%)
3-Yr Target (if PE normalizes)
(PE: 19→21)
$7.18
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: -9.8%)
$5.40
(+-25%)
Base:
(SPY PE: 19.4, Growth: -9.8%)
$5.28
(-27%)
Bear:
(PE: 16.5, Growth: -9.8%)
$4.49
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 19.4 to 20.8
Stabilization Target:
$7.70
(+7.2%)
PE Expansion Potential:
+7.2%
Share OFIX Analysis
Share this live OFIX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (OFIX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 7, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $OFIX with no recent news articles available.
Key Retail Themes:
Bullish sentiment towards $OFIX
Traders' investment decisions
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:07 PM ET
Data refreshes hourly during market hours. Next update: 4:07 PM
Data refreshes hourly during market hours. Next update: 4:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OFIX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 54 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
30 analysts |
$105 | 41 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
16 analysts |
$166 | 54 HOLD |
|
PODD
Insulet Corporation |
BUY
26 analysts |
$178 | 40 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive OFIX Research Pages
